Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cupric cation refers to the divalent form of the element copper (chemical symbol Cu^2+, also known as copper(II) or Cu(II)). It is a monoatomic dication and plays an essential biological role as a cofactor in various enzymatic processes. In medicine and nutrition, it is most commonly encountered as the active moiety in compounds such as cupric chloride or cupric sulfate. Clinically, it is used primarily as an additive in intravenous solutions for total parenteral nutrition to prevent or treat copper deficiency. The mechanism of action involves serving as a cofactor for enzymes involved in redox reactions and electron transport[1][2][5]. Excessive exposure can cause toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cupric cation.